Chronic Limb-Threatening Ischemia clinical trials at UCLA

3 in progress, 2 open to eligible people

Showing trials for

  • PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

    open to eligible people ages 18-95

    A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.

    Torrance, California and other locations

  • SELUTION4BTK Trial

    open to eligible people ages 18 years and up

    This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the BTK arteries in CLTI patients.

    Torrance, California and other locations

  • Pivotal Trial of the Boomerang Catheter for pDVA

    Sorry, accepting new patients by invitation only

    The purpose of this study is to establish the safety and effectiveness of the Boomerang Catheter for percutaneous Deep Venous Arterialization (pDVA) to treat no-option Chronic Limb-Threatening Ischemia.

    Sylmar, California and other locations

Our lead scientists for Chronic Limb-Threatening Ischemia research studies include .

Last updated: